-
AskBio Enters Research Collaboration with UNC
contractpharma
March 19, 2020
Collaboration builds upon preclinical research that demonstrates potential for gene therapy to correct deficiency in UBE3A gene.
-
Avectas, CCRM Enter Cell Therapy Tie-up
contractpharma
March 04, 2020
Collaboration to accelerate development of novel technology for cell therapies.
-
Nanoparticle gene therapy drug delivery for paediatric brain cancer tested in mice
europeanpharmaceuticalreview
January 13, 2020
A study has shown that PBAE nanoparticles could replace viral vectors in gene therapies and provide a safe treatment option for paediatric brain cancer patients.
-
BioMarin Submits CTA in UK for Investigational Gene Therapy for PKU
americanpharmaceuticalreview
September 27, 2019
BioMarin Pharmaceutical has submitted a Clinical Trial Application (CTA) with the Medicines and Healthcare Products Regulatory Agency (MHRA) in the U.K. for BMN 307 ...
-
Extinct Human Species Passed on Powerful Immune System Gene
drugs
September 24, 2019
You may have the extinct humans called Denisovans to thank for your adaptable immune system, Australian researchers suggest.
-
Gene-targeted cancer drugs, slow release overcome resistance
worldpharmanews
September 17, 2019
Biomedical engineers at Duke University have developed a method to address failures in a promising anti-cancer drug, bringing together tools from genome engineering, protein engineering and ...
-
Unique Gene Activity Discovered in People With Both Stroke and Cancer
drugs
September 16, 2019
Not all strokes have a clear-cut cause like high blood pressure or smoking. For those so-called cryptogenic strokes, new research suggests cancer might be the trigger ...
-
Alternative viral delivery of gene therapy developed
europeanpharmaceuticalreview
September 10, 2019
New nanocapsules are a promising platform for many types of gene therapies due to their small size and superior stability.
-
Lifestyle May Matter More Than Your Genes in Early Heart Disease
drugs
September 03, 2019
An unhealthy lifestyle is a bigger contributor to heart disease than genetics for many younger adults, according to a new study.
-
Pfizer invests half billion dollars to advance state-of-the-art gene therapy facility in Sanford, North Carolina
worldpharmanews
September 02, 2019
Pfizer announced an additional half billion dollar investment for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford...